Showing 97 to 108 of 215 results
Trump Administration Defends Mifepristone Access in Legal Challenge
The Trump administration is defending FDA rules easing access to the abortion drug mifepristone against a lawsuit by three Republican states, arguing they lack standing and Texas is an improper venue; this maintains current access levels, affecting abortion availability nationwide.
Trump Administration Defends Mifepristone Access in Legal Challenge
The Trump administration is defending FDA rules easing access to the abortion drug mifepristone against a lawsuit by three Republican states, arguing they lack standing and Texas is an improper venue; this maintains current access levels, affecting abortion availability nationwide.
Progress
44% Bias Score
Trump Administration Moves to Dismiss Lawsuit Challenging Mifepristone Access
The Trump administration filed to dismiss a lawsuit from Idaho, Kansas, and Missouri seeking to restrict telehealth access to the abortion medication mifepristone, arguing the states lack legal standing and that their challenge to 2016 FDA actions is beyond the statute of limitations.
Trump Administration Moves to Dismiss Lawsuit Challenging Mifepristone Access
The Trump administration filed to dismiss a lawsuit from Idaho, Kansas, and Missouri seeking to restrict telehealth access to the abortion medication mifepristone, arguing the states lack legal standing and that their challenge to 2016 FDA actions is beyond the statute of limitations.
Progress
44% Bias Score
FDA to Phase Out Artificial Food Dyes, Spurring Shift to Natural Alternatives
The FDA plans to phase out petroleum-based synthetic food dyes in the US food supply by 2027, prompting a shift to natural alternatives due to health concerns and following state-level bans on artificial dyes.
FDA to Phase Out Artificial Food Dyes, Spurring Shift to Natural Alternatives
The FDA plans to phase out petroleum-based synthetic food dyes in the US food supply by 2027, prompting a shift to natural alternatives due to health concerns and following state-level bans on artificial dyes.
Progress
36% Bias Score
FDA to Phase Out Artificial Food Dyes in US Food Supply
The US Food and Drug Administration (FDA) plans to work with the food industry to phase out petroleum-based synthetic dyes, such as Red No. 40 and Yellow No. 5, due to health concerns and following state bans on artificial food dyes; the FDA will also fast-track the approval of four new natural colo...
FDA to Phase Out Artificial Food Dyes in US Food Supply
The US Food and Drug Administration (FDA) plans to work with the food industry to phase out petroleum-based synthetic dyes, such as Red No. 40 and Yellow No. 5, due to health concerns and following state bans on artificial food dyes; the FDA will also fast-track the approval of four new natural colo...
Progress
40% Bias Score
HHS Mandates Placebo Trials for All New Vaccines, Raising Concerns for COVID-19 Updates
The U.S. HHS announced that all new vaccines will require placebo-controlled trials before authorization, potentially delaying updated COVID-19 vaccines and raising questions about current vaccine safety monitoring systems.
HHS Mandates Placebo Trials for All New Vaccines, Raising Concerns for COVID-19 Updates
The U.S. HHS announced that all new vaccines will require placebo-controlled trials before authorization, potentially delaying updated COVID-19 vaccines and raising questions about current vaccine safety monitoring systems.
Progress
52% Bias Score
FDA Reviews COVID-19 Vaccine Approvals for Next Winter Amid Data Concerns
The FDA is reviewing whether to approve COVID-19 vaccines for next winter due to insufficient data on booster shot effectiveness and low uptake, marking a shift from the previous administration's policy of annual updates.
FDA Reviews COVID-19 Vaccine Approvals for Next Winter Amid Data Concerns
The FDA is reviewing whether to approve COVID-19 vaccines for next winter due to insufficient data on booster shot effectiveness and low uptake, marking a shift from the previous administration's policy of annual updates.
Progress
44% Bias Score
Trump Administration Defends Mifepristone Access Amidst Legal Challenge
The Trump administration is defending FDA regulations easing access to the abortion drug mifepristone against a lawsuit by three Republican-led states, arguing the states lack standing to sue in Texas federal court, while the states claim their Medicaid programs might have to pay for complications.
Trump Administration Defends Mifepristone Access Amidst Legal Challenge
The Trump administration is defending FDA regulations easing access to the abortion drug mifepristone against a lawsuit by three Republican-led states, arguing the states lack standing to sue in Texas federal court, while the states claim their Medicaid programs might have to pay for complications.
Progress
32% Bias Score
FDA Recalls Vine-Ripe Tomatoes Over Salmonella Fears
The FDA recalled vine-ripe tomatoes sold in 11 states by Ray and Mascarim Inc. (UPC 7 96553 20062 1) due to potential salmonella contamination; no illnesses have been reported yet.
FDA Recalls Vine-Ripe Tomatoes Over Salmonella Fears
The FDA recalled vine-ripe tomatoes sold in 11 states by Ray and Mascarim Inc. (UPC 7 96553 20062 1) due to potential salmonella contamination; no illnesses have been reported yet.
Progress
36% Bias Score
HHS Mandates Placebo Trials for New Vaccines, Delaying COVID-19 Boosters
The US Department of Health and Human Services announced Wednesday that all new vaccines will require placebo-controlled trials before licensure, a change that experts warn could delay updated COVID-19 vaccines by months and put vulnerable populations at risk, despite assertions that current safety ...
HHS Mandates Placebo Trials for New Vaccines, Delaying COVID-19 Boosters
The US Department of Health and Human Services announced Wednesday that all new vaccines will require placebo-controlled trials before licensure, a change that experts warn could delay updated COVID-19 vaccines by months and put vulnerable populations at risk, despite assertions that current safety ...
Progress
52% Bias Score
FDA to Phase Out Artificial Food Dyes, Promoting Natural Alternatives
The FDA is urging US food companies to voluntarily replace petroleum-based synthetic dyes with natural alternatives due to health concerns, following state-level bans and a growing consumer preference for natural ingredients.
FDA to Phase Out Artificial Food Dyes, Promoting Natural Alternatives
The FDA is urging US food companies to voluntarily replace petroleum-based synthetic dyes with natural alternatives due to health concerns, following state-level bans and a growing consumer preference for natural ingredients.
Progress
32% Bias Score
FDA Plans to Phase Out Artificial Food Dyes in US Food Supply
The FDA announced plans to work with the food industry to phase out petroleum-based synthetic dyes in US foods due to health concerns, aiming to replace them with natural alternatives and expedite the approval of four new natural colorants, following state-level bans on several artificial dyes.
FDA Plans to Phase Out Artificial Food Dyes in US Food Supply
The FDA announced plans to work with the food industry to phase out petroleum-based synthetic dyes in US foods due to health concerns, aiming to replace them with natural alternatives and expedite the approval of four new natural colorants, following state-level bans on several artificial dyes.
Progress
36% Bias Score
Blood Tests to Improve Alzheimer's Detection and Treatment
New blood tests for Alzheimer's disease, showing up to 91% improved diagnostic accuracy in research, could significantly improve detection and treatment, allowing earlier intervention with new FDA-approved drugs like Leqembi and Kisunla, while the ALZ-NET system will track long-term effects.
Blood Tests to Improve Alzheimer's Detection and Treatment
New blood tests for Alzheimer's disease, showing up to 91% improved diagnostic accuracy in research, could significantly improve detection and treatment, allowing earlier intervention with new FDA-approved drugs like Leqembi and Kisunla, while the ALZ-NET system will track long-term effects.
Progress
32% Bias Score
Showing 97 to 108 of 215 results